Metabolism Associated With Abdominal Fat Mass Distribution

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-09-30

Study Completion Date

2012-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objectives:

The primary objective of this clinical trial is to characterize metabolic signatures associated with abdominal fat distribution in 40 women with different BMI 29-40 and different abdominal distribution of fat (visceral vs. sub-cutaneous fat).

No intervention with a product is planned. The subjects will be given one high fat meal with commercial products (eggs, milk, cream, bread, fruits, cheese and cheese) on one test day to test the post-prandial metabolic response.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obese

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

obese women fat mass distribution Metabolomic profiles

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No product is tested

No intervention

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI 29-40 kg/m2
* Aged 25-45

Exclusion Criteria

* Diagnosed metabolic disorder such as Diabetes type 1 and 2, cardiovascular disease, metabolic syndrome
* Pregnancy
* Any pathology (infectious or other) having required an antibiotic therapy within 1 month prior to the beginning of the study.
* Any therapy (contraception apart) within the run-in period of one week before the test day.
* Subject who cannot be expected to comply with treatments and measures.
* Subject who is affected by any specific eating disorder
* Currently participating or having participated in another clinical trial during the last 3 months prior to the beginning of this study.
* Subjects having recently undergone a weight loss of more than 3 kilos during the last 3 months

Minimum Eligible Age

25 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vittorio Giusti, MD, PD/MER

Role: PRINCIPAL_INVESTIGATOR

University Hospitals of Lausanne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nestlé Clinical Development Unit / Metabolic Unit

Lausanne, , Switzerland

Site Status

University Hospitals, Service of endocrinology, diabetology, and metabolism

Lausanne, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

08.02.NRC

Identifier Type: -

Identifier Source: org_study_id